0920-0263 Revision_Sup_Sta_B 04262017

0920-0263 Revision_Sup_Sta_B 04262017.docx

Requirements for the Importation of Nonhuman Primates into the United States

OMB: 0920-0263

Document [docx]
Download: docx | pdf










Requirements for the Importation of Nonhuman Primates into the United States


OMB Control No. 0920-0263

Exp 9/30/2017



Supporting Statement B



Request for Revision of Currently Approved Data Collection

May 2017

















Contact:


Lee Samuel

Office of Policy and Planning

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

1600 Clifton Road, N.E., MS C12

Atlanta, Georgia 30333

Phone: (404) 718-1616

Email: llj3@cdc.gov


B. Collection of Information Employing Statistical Methods


Statistical methods do not apply to this data collection. No statistical methods are used in this data collection. A registered importer must request a permit to import nonhuman primates into the U.S. To receive the permit, the importer must submit a written plan to the Director of CDC which specifies steps that will be taken to prevent exposure of persons and animals during the entire importation and quarantine process for the arriving non-human primates. This includes disease prevention procedures throughout the chain of custody of these nonhuman primates from embarkation in the country of origin to release from quarantine. Information such as species, origin, and intended use for primates, transit information, isolation and quarantine procedures, and procedures for tuberculosis and filovirus testing of quarantined nonhuman primates. CDC evaluates compliance with the standards and determines whether adequate measures being taken to prevent the exposure of persons and animals during importation, transportation, and quarantine.


CDC monitors at least two shipments of non-human primates to be assured that the provisions of a permit are being followed by a new permit holder. Once CDC is assured that adequate disease control practices are being used by new permit holders, the permit can be extended to cover the receipt of additional shipments under the same plan for a period of two years and may be renewed upon request.


Concerning this information collection, there will be no sampling of importers seeking to bring live nonhuman primates or nonhuman primate products.


1. Respondent Universe and Sampling Methods


There are no sampling methods employed for this data collection as the importation of these animals is covered by a regulatory requirement. The respondent universe is all animal importers who want to import nonhuman primates and nonhuman primate products into the United States.


2. Procedures for the Collection of Information


A registered importer must request a permit to import nonhuman primates into the U.S. To receive the permit, the importer must submit a written plan to the Director of CDC which specifies steps that will be taken to prevent exposure of persons and animals during the entire importation and quarantine process for the arriving nonhuman primates. This includes disease prevention procedures throughout the chain of custody of these primates from embarkation in the country of origin to release from quarantine. Information such as species, origin, and intended use for primates, transit information, isolation and quarantine procedures, and procedures for tuberculosis and filovirus testing of quarantined animals. CDC evaluates compliance with the standards and determines whether adequate measures being taken to prevent the exposure of persons and animals during importation.


With regard to this information collection, information pertaining to the importation of nonhuman primate and nonhuman primate products will be accomplished when individuals arrive at ports of entry and must be done so through the ITDS/ACE systems using the Document Imaging System. Importers are required to provide documentation clearly indicating that nonhuman primate products have been rendered non-infectious, and this documentation must be submitted using the Document Imagine System provided by Customs and Border Protection.


CDC monitors at least two shipments of nonhuman primates to be assured that the provisions of a permit are followed by a new permit holder. Once CDC confirms that adequate disease control practices are used by new permit holders, the permit can be extended to cover the receipt of additional shipments under the same plan for a period of two years and may be renewed upon request.


3. Methods to Maximize Response Rates and Deal with No response


Concerning this information collection, electronic submission of information concerning the importation of CDC-regulated products via ITDS/ACE Document Imaging System is mandatory. The information collected for the import permit is required in the event that any registered importer wants to import nonhuman primates into the U.S. If the importer does not comply with each part of the permit application, required notification to CDC for arrival, quarantine release, documentation requirements, or submit to required testing procedures for tuberculosis or filoviruses, importation is not permitted and the importer may lose their permit. It is in the importers interest to respond to the requirements for the permit if indeed it intends to import the specified animals.


Importers are also required to provide documentation clearly indicating that nonhuman primate products have been rendered non-infectious, and this documentation may be submitting using the Document Imagine System provided by Customs and Border Protection. Without this documentation, the import may not enter the United States.


4. Tests of Procedures or Methods to be Undertaken


The information pertaining to nonhuman primate shipments, documentation requirements, notifications to CDC, and tuberculosis and filovirus testing collected from the importers is defined by regulations and requirements set by CDC. No tests of procedures or questions were performed. This program has a long history and has functioned well.


5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data


There are no statistical aspects of the information collected and no statistical consultants were contacted. Collection and review of the information is the responsibility of CDC’s Division of Global Migration and Quarantine.

4


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorReichard, Jessica (CDC/OID/NCEZID) (CTR)
File Modified0000-00-00
File Created2021-01-22

© 2024 OMB.report | Privacy Policy